IP Library › Granted Patent US 11,649,266
Granted Patent B2
US 11,649,266 · App. 17/111,115 · Granted May 16, 2023

Insecticidal polypeptides having improved activity spectrum and uses thereof

Inventors: Michi Izumi Willcoxon (Palo Alto, CA); Takashi Yamamoto (Dublin, CA)
C07K14/325A01N37/46A01N63/10A01N63/50A01N65/22A01N65/44C12N15/8286Y02A40/146
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,649,266
App. No.
17/111,115
Granted
May 16, 2023
Kind
B2
Abstract

The disclosure provides nucleic acids, and variants and fragments thereof, derived from strains of Bacillus thuringiensis encoding variant polypeptides having increased pesticidal activity against insect pests, including Lepidoptera and Coleopteran. Particular embodiments of the disclosure provide isolated nucleic acids encoding pesticidal proteins, pesticidal compositions, DNA constructs, and transformed microorganisms and plants comprising a nucleic acid of the embodiments. These compositions find use in methods for controlling pests, especially plant pests.

Claims (4)

1. A variant Cry1B polypeptide, wherein the variant Cry1B polypeptide comprises an amino acid sequence having at least 98% sequence identity to SEQ ID NO: 29, wherein the variant Cry1B polypeptide comprises conserved amino acid residues Serine (S) at position 168, a Glutamine (Q) at position 172, a Threonine (T) at position 490, a Leucine (L) at position 491, an Aspartic acid (D) at position 496, a Glutamic acid (E) at position 498, and an Asparagine (N) at position 501.

2. The variant Cry1B polypeptide of claim 1 , wherein the variant Cry1B polypeptide comprises an amino acid sequence having at least 99% sequence identity to SEQ ID NO: 29.

3. A composition comprising the variant Cry1B polypeptide of claim 1 .

4. The composition of claim 3 , wherein the composition comprises from 1% to 99% by weight of the variant Cry1B polypeptide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2020
From: WILLCOXON, MICHI IZUMI; YAMAMOTO, TAKASHI
To: PIONEER HI-BRED INTERNATIONAL, INC.
Reel/Frame 054695/0944 →
Continuity (3)
Continuation 15518677
Provisional Application 62064877 · Oct 16, 2014
Related Publication 20210147492A1 · May 20, 2021
Cited By (1)
US 12,391,730